Cover Image
Market Research Report

KOL Perspectives: Adaptive Trial Designs in IBD

Published by GlobalData Product code 750170
Published Content info 27 Pages
Delivery time: 1-2 business days
Price
Back to Top
KOL Perspectives: Adaptive Trial Designs in IBD
Published: August 22, 2018 Content info: 27 Pages
Description

This KOL Insight briefing focuses on KOLs views of Adaptive trial designs in IBD.

Questions topics:

  • Current challenges in IBD clinical trials
  • Adaptive Phase II/III trial designs
  • Guselkumab's Phase II/III trial in Crohn's disease
  • Novel clinical trials in IBD

Key Highlights:

  • Most KOLs highlighted that recruitment is the greatest challenge in IBD clinical trials, both across Crohn's disease & UC
  • Most KOLs flagged Phase II/III trials could accelerate development, but may limit ability to analyze data & adapt trial design
  • Most KOLs cited 8-12 weeks as being the minimum duration of a Phase II trial in IBD, with open-label extensions favored by all KOLs.

Scope:

  • The insight briefing is based on Sociable Pharma's analysis of primary research with our IBD key opinion leaders (KOLs).

In total, we conducted interviews with 10 KOLs -

  • 5 Europe-based & 5 N. America-based
  • Interviews performed during July 2018

KOL data is analyzed to produce -

  • Charts summarizing KOL opinions
  • Chart call-outs of key information & details
  • KOL quotes
  • Summary of KOL reporting trends
  • Insight from Sociable Pharma's analysts

Reasons to buy:

  • Combines Qualitative & semi-quantitative insight from key opinion leaders on Adaptive trial designs in IBD
  • Includes insight & recommendations from our disease-specific healthcare analysts
  • Utilizes independent expert viewpoints to validate the impact of new clinical data & emerging trends on management of IBD
  • Provides cost-effective support for your advisory boards, with topics acting as a catalyst for further expert discussion.
Table of Contents
Product Code: GDHC057SP

Table of Contents

  • Executive Summary
  • Background
  • Research Panel Composition
  • Results & Implications
  • Appendix
Back to Top